Kallmann Syndrome clinical trials
The registry lists 23 studies for Kallmann Syndrome across 5 countries. 5 are recruiting or about to start. 17 of them are mainly about Kallmann Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Kallmann Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Massachusetts General Hospital (8) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · Centre Hospitalier Universitaire Vaudois (2) · National Institute of Environmental Health Sciences (NIEHS) (2) · Boston College (1) · Tongji Hospital (1) · dr. Laura C. G. de Graaff-Herder (1) · Stephanie B. Seminara, MD (1)
What is being tested here
Drugs under test in Kallmann Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
Of the 4 Kallmann Syndrome studies recruiting now, 2 (50%) set no upper age limit and 1 (25%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 1 (25%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (50%) | 2 (50%) |
| 18 | 3 (75%) | 4 (100%) |
| 30 | 3 (75%) | 4 (100%) |
| 40 | 3 (75%) | 4 (100%) |
| 50 | 3 (75%) | 3 (75%) |
| 65 | 3 (75%) | 3 (75%) |
| 75 | 3 (75%) | 3 (75%) |
| 85 | 3 (75%) | 3 (75%) |
Across all 23 studies, recruiting or not: 48% stop at 75 or younger and 35% at 65; 52% take children; 9% are for women only and 35% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Inherited Reproductive DisordersRecruitingNCT015004471 country
- GROWing Up With Rare GENEtic SyndromesRecruitingNCT044633161 country
- Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or PalateRecruitingNCT016011711 country
- Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)RecruitingNCT03687606Phase 41 country
- A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in FinlandEnrolling by invitationNCT00623116Not applicable1 country
- Hormonal Regulation of Puberty and FertilityCompletedNCT015115881 country
- The Molecular Basis of Inherited Reproductive DisordersCompletedNCT059718361 country
- Patient and Healthcare Professional Views on Genetic/Genomic Information and TestingActive, not recruitingNCT047332741 country
- Kisspeptin Administration in the AdultCompletedNCT00914823Phase 11 country
- Kisspeptin in the Evaluation of Delayed PubertyCompletedNCT01438034Phase 11 country
- Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)CompletedNCT00392756Phase 11 country
- Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With HypogonadismCompletedNCT00493961Phase 11 country
- Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive DisordersCompletedNCT004941691 country
- Psychological Outcomes in Isolated GnRH DeficiencyTerminatedNCT023561721 country
- Health Needs of Patients With Kallmann SyndromeCompletedNCT019141721 country
- Pulsatile GnRH in Anovulatory InfertilityStatus unknownNCT00383656Phase 21 country
- Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With HypogonadismTerminatedNCT00064987Phase 21 country
- Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)TerminatedNCT03118479Phase 11 country
- Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic HypogonadismStatus unknownNCT02880280Phase 41 country
- Investigating the Regulation of Reproductive Hormones in Adult MenCompletedNCT00392457Not applicable1 country
- Baselines in Reproductive DisordersStatus unknownNCT00456274Not applicable1 country
- Sequential Therapy for Hypogonadotropic HypogonadismCompletedNCT01403532Phase 41 country
- Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH MenCompletedNCT00470990Not applicable1 country